Basic Information
| RNALocate ID: | RLID:11001631 |
| RNA Symbol: | hsa-let-7g-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-let-7g-5p |
| RNA ID: | miRBase:MIMAT0000414 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001694 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001695 | Cytoplasm | HeLa cells | 22058130 |
| RLID:01001696 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001697 | Mitochondrion | HEK-293 cells|HeLa cells|Myotube | 27396686 |
| RLID:01001698 | Mitochondrion | HEK-293 cells|HeLa cells|Skeletal muscle cells | 27563705 |
| RLID:01001699 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001700 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001701 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001702 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001703 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001704 | Nucleus | HeLa cells | 22058130 |
| RLID:11001622 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
| RLID:11001623 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
| RLID:11001624 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001625 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001626 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001627 | Exosome | Breast milk | 22211110 |
| RLID:11001628 | Exosome | Epidermal melanocytes (HEMa-LP)|Malignant melanoma cell line (A375) | 23056502 |
| RLID:11001629 | Exosome | Saliva | 23302638 |
| RLID:11001630 | Exosome | Brain tissue | 23382797 |
| RLID:11001632 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
| RLID:11001633 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001634 | Microvesicle | Plasma | 19002258 |
| RLID:11001635 | Microvesicle | Plasma | 23077538 |
| RLID:11001636 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001637 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11001638 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000068 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000342 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-let-7g-5p | Diffuse large b cell lymphoma | MNDR-E-MI-01982 |
| MNDR | hsa-let-7g-5p | Splenic marginal zone lymphoma | MNDR-E-MI-01983 |
| MNDR | hsa-let-7g-5p | Oral squamous cell carcinoma | MNDR-E-MI-01984 |
| MNDR | hsa-let-7g-5p | B cell lymphoma of malt type | MNDR-E-MI-01985 |
| MNDR | hsa-let-7g-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-01986 |
| MNDR | hsa-let-7g-5p | Lymphoma | MNDR-E-MI-01987 |
| MNDR | hsa-let-7g-5p | Lymphoma non-hodgkin | MNDR-E-MI-01988 |
| MNDR | hsa-let-7g-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-01989 |
| MNDR | hsa-let-7g-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-01990 |
| MNDR | hsa-let-7g-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-01991 |
| MNDR | hsa-let-7g-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-01992 |
| MNDR | hsa-let-7g-5p | Breast cancer luminal | MNDR-E-MI-01993 |
| MNDR | hsa-let-7g-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-01994 |
| MNDR | hsa-let-7g-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-01995 |
| MNDR | hsa-let-7g-5p | Prostate cancer | MNDR-E-MI-01996 |
| MNDR | hsa-let-7g-5p | Gastric cancer | MNDR-E-MI-01997 |
| MNDR | hsa-let-7g-5p | Gastric lymphoma | MNDR-E-MI-01998 |
| MNDR | hsa-let-7g-5p | Alzheimer disease | MNDR-E-MI-01999 |
| MNDR | hsa-let-7g-5p | Dysautonomia familial | MNDR-E-MI-02000 |
| MNDR | hsa-let-7g-5p | Head and neck cancer | MNDR-E-MI-02001 |
| MNDR | hsa-let-7g-5p | Malaria | MNDR-E-MI-02002 |
| MNDR | hsa-let-7g-5p | Leukemia | MNDR-E-MI-02003 |
| MNDR | hsa-let-7g-5p | Cardiovascular disease | MNDR-E-MI-02004 |
| MNDR | hsa-let-7g-5p | Lung cancer | MNDR-E-MI-02005 |
| MNDR | hsa-let-7g-5p | Metabolic syndrome x | MNDR-E-MI-02006 |
| MNDR | hsa-let-7g-5p | Parkinson disease | MNDR-E-MI-02007 |
| MNDR | hsa-let-7g-5p | Breast cancer | MNDR-E-MI-02008 |
| MNDR | hsa-let-7g-5p | Thyroid cancer | MNDR-E-MI-02009 |
| MNDR | hsa-let-7g-5p | Pancreatic cancer | MNDR-E-MI-02010 |
| MNDR | hsa-let-7g-5p | Melanoma | MNDR-E-MI-02011 |
| MNDR | hsa-let-7g-5p | Rectum adenocarcinoma | MNDR-E-MI-02012 |
| MNDR | hsa-let-7g-5p | Nephroblastoma | MNDR-E-MI-02013 |
| MNDR | hsa-let-7g-5p | Colon cancer | MNDR-E-MI-02014 |
| MNDR | hsa-let-7g-5p | Ischemic attack transient | MNDR-E-MI-02015 |
| MNDR | hsa-let-7g-5p | Colon adenocarcinoma | MNDR-E-MI-02016 |
| MNDR | hsa-let-7g-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-02017 |
| MNDR | hsa-let-7g-5p | Familial ovarian cancer | MNDR-E-MI-02018 |
| MNDR | hsa-let-7g-5p | Prostate adenocarcinoma | MNDR-E-MI-02019 |
| MNDR | hsa-let-7g-5p | Carcinoma ductal breast | MNDR-E-MI-02020 |
| MNDR | hsa-let-7g-5p | Glioblastoma | MNDR-E-MI-02021 |
| MNDR | hsa-let-7g-5p | Malignant glioma | MNDR-E-MI-02022 |
| MNDR | hsa-let-7g-5p | Chordoma | MNDR-E-MI-02023 |
| MNDR | hsa-let-7g-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-02024 |
| MNDR | hsa-let-7g-5p | Liposarcoma | MNDR-E-MI-02025 |
| MNDR | hsa-let-7g-5p | Liver cancer | MNDR-E-MI-02026 |
| MNDR | hsa-let-7g-5p | Uterine cancer | MNDR-E-MI-02027 |
| MNDR | hsa-let-7g-5p | Cervical adenocarcinoma | MNDR-E-MI-02028 |
| MNDR | hsa-let-7g-5p | Gastric adenocarcinoma | MNDR-E-MI-02029 |
| MNDR | hsa-let-7g-5p | Non-small cell lung cancer | MNDR-E-MI-02030 |
| MNDR | hsa-let-7g-5p | Lung adenocarcinoma | MNDR-E-MI-02031 |
| MNDR | hsa-let-7g-5p | Adrenocortical cancer | MNDR-E-MI-02032 |
| MNDR | hsa-let-7g-5p | Thyroid carcinoma | MNDR-E-MI-02033 |
| MNDR | hsa-let-7g-5p | Tuberculosis | MNDR-E-MI-02034 |
| MNDR | hsa-let-7g-5p | Carcinoma renal cell | MNDR-E-MI-02035 |
| MNDR | hsa-let-7g-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-02036 |
| MNDR | hsa-let-7g-5p | Clear cell renal cell carcinoma | MNDR-E-MI-02037 |
| MNDR | hsa-let-7g-5p | Biliary tract cancer | MNDR-E-MI-02038 |
| MNDR | hsa-let-7g-5p | Cholangiocarcinoma | MNDR-E-MI-02039 |
| MNDR | hsa-let-7g-5p | Esophageal cancer | MNDR-E-MI-02040 |
| MNDR | hsa-let-7g-5p | Liver cirrhosis | MNDR-E-MI-02041 |
| MNDR | hsa-let-7g-5p | Testicular germ cell cancer | MNDR-E-MI-02042 |
| MNDR | hsa-let-7g-5p | T acute lymphoblastic leukemia | MNDR-E-MI-02043 |
| MNDR | hsa-let-7g-5p | Acute t cell leukemia | MNDR-E-MI-02044 |
| MNDR | hsa-let-7g-5p | Breast invasive carcinoma | MNDR-E-MI-02045 |
| MNDR | hsa-let-7g-5p | Early hepatocellular carcinoma | MNDR-E-MI-02046 |
| MNDR | hsa-let-7g-5p | Familiar ovarian carcinoma | MNDR-E-MI-02047 |
| MNDR | hsa-let-7g-5p | B-cell lymphoma | MNDR-E-MI-02048 |
| MNDR | hsa-let-7g-5p | Rheumatoid arthritis | MNDR-E-MI-02049 |
| MNDR | hsa-let-7g-5p | T-cell leukemia | MNDR-E-MI-02050 |
| MNDR | hsa-let-7g-5p | Neuroblastoma | MNDR-E-MI-02051 |
| MNDR | hsa-let-7g-5p | Hodgkin lymphoma | MNDR-E-MI-02052 |
| MNDR | hsa-let-7g-5p | Burkitt lymphoma | MNDR-E-MI-02053 |
| MNDR | hsa-let-7g-5p | Neurological disease | MNDR-E-MI-02054 |
| MNDR | hsa-let-7g-5p | Crohn disease | MNDR-E-MI-02055 |
| MNDR | hsa-let-7g-5p | Neuromyelitis optica | MNDR-E-MI-02056 |
| MNDR | hsa-let-7g-5p | Acute myelogenous leukemia | MNDR-E-MI-02057 |
| MNDR | hsa-let-7g-5p | Colorectal cancer | MNDR-E-MI-02058 |
| MNDR | hsa-let-7g-5p | Nasopharynx carcinoma | MNDR-E-MI-02059 |
| MNDR | hsa-let-7g-5p | Multiple myeloma | MNDR-E-MI-02060 |
| MNDR | hsa-let-7g-5p | Nasopharyngeal cancer | MNDR-E-MI-02061 |
| MNDR | hsa-let-7g-5p | Prostatic neoplasms | MNDR-E-MI-02062 |
| MNDR | hsa-let-7g-5p | High grade dysplastic nodule | MNDR-E-MI-02063 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCC10 | Homo sapiens | RR00023406 |
TOP